Cargando…
Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR/Cas9 technology
BACKGROUND: Hemophilia B is a rare inherited genetic bleeding disorder caused by a deficiency or lack of coagulation factor IX, the gene for which (F9) is located on the X chromosome. Hemophilia B is currently incurable and the standard treatment is coagulation factor replacement therapy. Although g...
Autores principales: | Ma, Yanchun, Sun, Wenwen, Zhao, Lidong, Yao, Mingze, Wu, Changxin, Su, Pengfei, Yang, Linhua, Wang, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327398/ https://www.ncbi.nlm.nih.gov/pubmed/35883203 http://dx.doi.org/10.1186/s13287-022-03036-2 |
Ejemplares similares
-
Loss of Dip2b leads to abnormal neural differentiation from mESCs
por: Yao, Mingze, et al.
Publicado: (2023) -
CRISPR-Mediated Knockout of Long 3′ UTR mRNA Isoforms in mESC-Derived Neurons
por: Bae, Bongmin, et al.
Publicado: (2021) -
Dichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency
por: Rodrigues, Ana Sofia, et al.
Publicado: (2015) -
A Model-Based Analysis of Culture-Dependent Phenotypes of mESCs
por: Herberg, Maria, et al.
Publicado: (2014) -
A method for stabilising the XX karyotype in female mESC cultures
por: Keniry, Andrew, et al.
Publicado: (2022)